A tetrameric protein called transthyretin (TTR), formerly known as thyroxine-binding prealbumin, transports hormones in the brain and plasma. Thyroid hormones and vitamin A are more easily transported in the blood and cerebrospinal fluid thanks to the complex it forms with retinol-binding protein (RBP). TTR has a negative correlation with inflammation and a positive indicator of nutrition status. TTR functions as a neuroprotective and anti-oxidative stress agent. Mutations, oxidative modifications, aging, proteolysis, and metal cations, such as Ca2+, all cause the TTR structure to become unstable. Senile and familial amyloidopathies are caused by amyloid deposits created by destabilized TTR molecules.
| Structure | Cat No. | Product Name | CAS No. | Product Description |
|---|---|---|---|---|
|
V70111 | Acoramidis hydrochloride (AG10 hydrochloride) | 2242751-53-5 | Acoramidis (AG10) HCl is an orally bioactive, selective stabilizer of transthyretin (TTR (transthyretin)), effective against both wild-type and V1221 mutants. |
|
V131921 | Cliramitug | 2965214-50-8 | Cliramitug is a monoclonal antibody that targets human transthyretin (TTR). |
|
V132076 | Coramitug | 2626841-92-5 | Coramitug is an anti-TTR human IgG1κ monoclonal antibody. |
|
V70112 | Eplontersen sodium | 2131025-75-5 | Eplontersen sodium is a triantennary, N-acetylgalactosamine (GalNAc3)-conjugated antisense oligonucleotide that targets transthyretin TTR mRNA and inhibits variant and wild-type TTR production. |
|
V135180 | Eplontersen sodium scrambled negative control | The Eplontersen sodium scrambled negative control is a negative control for Eplontersen sodium with a scrambled sequence. | |
|
V137000 | Guanidino-G-Clamp-PNA | 476667-31-9 | Guanidino-G-Clamp-PNA is a highly efficient sequence-specific RNA binder and gene silencing agent. |
|
V115137 | Human prealbumin | Human prealbumin (human transthyretin) is a homotetrameric protein mainly synthesized by the liver and choroid plexus. | |
|
V70110 | Inotersen sodium (ISIS-420915 sodium) | 1432726-13-0 | Inotersen (ISIS-420915) sodium is a 2'-O-methoxyethyl modified antisense oligonucleotide. |
|
V137973 | Inotersen sodium scrambled negative control | The Inotersen sodium scrambled negative control is a negative control for Inotersen sodium with a scrambled sequence. | |
|
V141326 | NI-301 | NI-301 is a human monoclonal antibody (mAb) that targets transthyretin/TTR. | |
|
V116868 | Nucresiran | Nucresiran is an siRNA that can inhibit the synthesis of wild-type and variant transthyretin protein mRNA in the liver. | |
|
V116821 | Nucresiran sodium | Nucresiran sodium is a siRNA that can inhibit the synthesis of wild-type and variant transthyretin protein mRNA in the liver. | |
|
V141707 | Nucresiran sodium scrambled negative control | The Nucresiran sodium scrambled negative control is a negative control with the sequence of Nucresiran sodium scrambled. | |
|
V70106 | Patisiran sodium | 1386913-72-9 | Patisiran sodium is a double-stranded small interfering RNA that targets sequences within the Transthyretin (TTR) messenger RNA. |
|
V81150 | PITB | PITB is a selective, orally bioactive inhibitor of transthyretin (TTR) aggregation. | |
|
V4862 | Tafamidis | 594839-88-0 | Tafamidis (also known as Fx-1006 or PF-06291826; Vyndaqel and Vyndamax), a potent and selective transthyretin (TTR)stabilizer, is a medication approved for use in delaying disease progression in adults with certain forms of transthyretin amyloidosis. |
|
V87853 | Transthyretin-IN-2 | 4664-62-4 | Transthyretin-IN-2 (Compound 36) is a transthyretin (TTR) amyloidosis inhibitor with IC50 and pIC50 values of 1.31 μM and 5.88 μM, respectively. |
|
V87852 | Transthyretin-IN-3 | 3008535-20-1 | Transthyretin-IN-3 (compound 6) is a designed benzofuran analog. |
|
V146376 | Transthyretin-IN-4 | 2765296-93-1 | Transthyretin-IN-4 is a bivalent inhibitor of transthyretin (TTR) amyloidosis (bIC50: 0.09 µM, pIC50: 1.4 µM). |
|
V97925 | TTR stabilizer 1 | 2778162-15-3 | TTR stabilizer 1 (Compound 1) is a stabilizer of transthyretin (TTR) with an EC50 value of 0.031 μM. |